A new procedure developed at Massachusetts General Hospital (MGH) may revolutionize the culturing of adult stem cells. In their report that has been published online prior to its appearance in the August 6 issue of Cell Stem ...
Cell & Microbiology
Jun 16, 2016
0
13
A team of researchers from Massachusetts General Hospital (MGH) and the Rowland Institute at Harvard University have used a specialized nanoprobe developed by the Harvard/Rowland investigators to directly measure levels of ...
Bio & Medicine
Jun 14, 2016
0
36
A Massachusetts General Hospital (MGH) research team investigating how the earliest stages of life might have developed has discovered a way the first living cells could have met a key challenge—maintaining a constant internal ...
Biochemistry
Mar 14, 2016
1
5
Researchers from the Massachusetts General Hospital (MGH) Division of Infectious Diseases are investigating the mechanism by which several important pathogenic species of bacteria deliver proteins into the cells of the organisms ...
Cell & Microbiology
Mar 9, 2016
0
12
A nanoparticle drug-delivery system that combines two complementary types of anticancer treatment could improve outcomes for patients with pancreatic cancer and other highly treatment-resistant tumors while decreasing toxicity. ...
Bio & Medicine
Jan 19, 2016
0
37
A new engineered version of the gene-editing CRISPR-Cas9 nuclease appears to robustly abolish the unwanted, off-target DNA breaks that are a significant current limitation of the technology, reducing them to undetectable ...
Biotechnology
Jan 6, 2016
6
165
A team of Massachusetts General Hospital (MGH) investigators has shown that a method they developed to improve the usefulness and precision of the most common form of the gene-editing tools CRISPR-Cas9 RNA-guided nucleases ...
Biotechnology
Nov 2, 2015
0
48
A team of Massachusetts General Hospital (MGH) researchers has found a way to expand the use and precision of the powerful gene-editing tools called CRISPR-Cas9 RNA-guided nucleases. In their report receiving advance online ...
Biotechnology
Jun 22, 2015
0
59
The latest version of a microfluidic device for capturing rare circulating tumor cells (CTCs) is the first designed specifically to capture clusters of two or more cells, rather than single cells. The new device called the ...
Analytical Chemistry
May 18, 2015
0
39
A device developed by Massachusetts General Hospital investigators may bring rapid, accurate molecular diagnosis of tumors and other diseases to locations lacking the latest medical technology. In their report appearing in ...
Engineering
Apr 13, 2015
0
535
